DeepMed Research

University of Oxford

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private

Established: 1096-01-01

Employees: 10K

Market Cap: -

Website: http://www.ox.ac.uk

Clinical Trials

Class II Invariant Chain HCV Vaccine Study

Phase 1

Completed

Conditions: Hepatitis C

Interventions: Biological: ChAd3-hliNSmut
Biological: MVA-hliNSmut

First Posted Date: 2018-09-27

Last Posted Date: 2023-05-10

Lead Sponsor: University of Oxford

Target Recruit Count: 25

Registration Number: NCT03688061

Locations: 🇬🇧
Centre for Cinical Vaccinology and Tropical Medicine, Univeristy of Oxford, Oxford, Oxfordshire, United Kingdom
🇬🇧
Hepatology Clinical Trial Unit, John Radcliffe Hospital, Oxford, Oxfordshire, United Kingdom

EMaBS TB Vaccine Study

Phase 1

Completed

Conditions: Immunogenicity
Safety

Interventions: Biological: ChAdOx185A
Biological: MVA85A
Biological: BCG

First Posted Date: 2018-09-24

Last Posted Date: 2022-08-05

Lead Sponsor: University of Oxford

Target Recruit Count: 72

Registration Number: NCT03681860

Locations: 🇺🇬
MRC/UVRI and LSHTM Uganda Research Unit, Entebbe Hospital, Entebbe, Uganda
🇬🇧
Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Churchill Hospital, Oxford, Oxfordshire, United Kingdom

Pramipexole and Emotional Processing

Not Applicable

Completed

Conditions: Reward
Emotions
Motivation
Dopamine

Interventions: Drug: Placebo
Drug: Pramipexole

First Posted Date: 2018-09-24

Last Posted Date: 2020-03-24

Lead Sponsor: University of Oxford

Target Recruit Count: 43

Registration Number: NCT03681509

Locations: 🇬🇧
Dept of Psychiatry, University of Oxford, Oxford, Oxfordshire, United Kingdom

Echocardiography: Value and Accuracy at REst and STress

Conditions: Angina Pectoris
Ischaemic Heart Disease
Coronary Artery Disease

First Posted Date: 2018-09-17

Last Posted Date: 2020-03-10

Lead Sponsor: University of Oxford

Target Recruit Count: 23000

Registration Number: NCT03674255

Novel Pleural Fluid, Biopsy and Serum Biomarkers for the Investigation of Pleural Effusions

Completed

Conditions: Pleural Effusion
Respiratory Disease
Lung Cancer

First Posted Date: 2018-09-07

Last Posted Date: 2020-11-05

Lead Sponsor: University of Oxford

Target Recruit Count: 313

Registration Number: NCT03661801

Locations: 🇬🇧
Oxford University Hospitals NHS Foundation Trust, Oxford, Oxfordshire, United Kingdom

The PIP Study - Pre- IVF Immune Profiling Study

Conditions: Sub-fertility
Recurrent Implantation Failure

First Posted Date: 2018-09-07

Last Posted Date: 2018-10-29

Lead Sponsor: University of Oxford

Target Recruit Count: 250

Registration Number: NCT03660735

Locations: 🇬🇧
IVI Oxford, Oxford, United Kingdom
🇬🇧
Wolfson Fertility Centre, London, United Kingdom

M6620 Plus Standard Treatment in Oesophageal and Other Cancer

Phase 1

Completed

Conditions: Oesophageal Adenocarcinoma
Squamous Cell Carcinoma
Solid Tumor

Interventions: Drug: M6620
Drug: Cisplatin
Drug: Capecitabine
Radiation: Radiotherapy

First Posted Date: 2018-08-22

Last Posted Date: 2024-07-18

Lead Sponsor: University of Oxford

Target Recruit Count: 36

Registration Number: NCT03641547

Locations: 🇬🇧
St James's University Hospital, Leeds, United Kingdom
🇬🇧
The Christie, Manchester, United Kingdom
🇬🇧
Velindre Cancer Centre, Cardiff, United Kingdom

and more 2 locations

Monitoring of Perfusion in Sepsis and Malaria

Completed

Conditions: Malaria
Severe Sepsis

Interventions: Procedure: Lung Ultrasound examination
Procedure: Compression ultrasonography (CUS)
Procedure: Echocardiography
Procedure: Inferior Vena Cava ultrasound
Procedure: Passive leg raising test (PLR)
Procedure: Orthogonal polarization spectral imaging (OPS)
Procedure: Urine collection (Foley catheter)
Procedure: Venous blood samplings
Procedure: Electrocardiogram
Procedure: GlycoCheck

First Posted Date: 2018-08-22

Last Posted Date: 2021-06-21

Lead Sponsor: University of Oxford

Target Recruit Count: 103

Registration Number: NCT03641534

Locations: 🇧🇩
Chittagong Medical College Hospital, Chittagong, Bangladesh

Intravenous Iron in Adults With Cystic Fibrosis

Phase 4

Completed

Conditions: Cystic Fibrosis
Iron-deficiency

Interventions: Drug: Ferric carboxymaltose

First Posted Date: 2018-08-15

Last Posted Date: 2022-09-07

Lead Sponsor: University of Oxford

Target Recruit Count: 20

Registration Number: NCT03632525

Locations: 🇬🇧
John Radcliffe Hospital, Oxford, United Kingdom

A Functional Magnetic Resonance Imaging Investigation of Transcranial Direct Current Stimulation

Not Applicable

Completed

Conditions: Anxiety State

Interventions: Other: transcranial direct current stimulation

First Posted Date: 2018-08-09

Last Posted Date: 2018-08-09

Lead Sponsor: University of Oxford

Target Recruit Count: 18

Registration Number: NCT03623815

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy